Aggressive axonal injury after acute inflammatory events in patients with multiple sclerosis (MS), and rapidly progressive neurodegenerative diseases with a predominant affection of the central motor system such as amyotrophic lateral sclerosis (ALS), result in a clear pathological increase of the CSF-NFL levels (1–3). This evidence concerns the gene NEFL and myeloid sarcoma.